MAY 03, 2024
Days after AstraZeneca acknowledged that its COVID vaccine can lead to a rare blood clot side effect, the parents of a young woman who allegedly died after being given Covishield are planning to sue the British pharma giant and world’s largest vaccine maker.
The development comes after AstraZeneca admitted in the UK court that their vaccine can cause rare side effects that can lead to blood clots and low platelet count.
Notably, while AstraZeneca developed the COVID-19 vaccine, it was manufactured in India by the Serum Institute of India (SII) under the name ‘Covishield’. The vaccine was widely administered in the country. However, SII is yet to comment on this matter. Reacting on AstraZeneca admission, Venugopalan Govindan, who lost his 20-year-old daughter Karunya in 2021, said the admission was “too late” and came after “so many lives have been lost”.
Taking to X, he wrote, “The Serum Institute should have stopped the vaccine supply after the 15 European countries had restricted its usage over deaths from blood clots.” He said the grieving parents are fighting for justice in various courts, but are not getting a hearing.
As we have repeatedly stated, the health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organisations take concrete steps together to identify the risks and to control and resolve them. – Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures, Jun Ueda, Hideyuki Motohashi, Yuriko Hirai, Kenji Yamamoto, Yasufumi Murakami, Masanori Fukushima, Akinori Fujisawa, Non-peer reviewed version published 15 March 2024.
